RT in combination with different forms of immunotherapy, such as anti-PD-1, and anti-CTLA4 antibodies, consistently improves local tumor control and leads to improved systemic tumor control (termed the abscopal effect) [28]; however, relapses often occur. The gene discussed is CTLA4; the disease is neoplasm.